CASH COW

[Carlito]

SPPH .29 , still on watch ,next week !!!!





Website:

http://www.spencerpharmaceutical.com
Phone: [phone]
Email: [e-mail]


Update Company Info Business Description


Spencer Pharmaceutical is a multi disciplinary company, which develops several patented drug platforms technologies for the treatment of Neurological diseases such as Alzheimer, Parkinson, and Multiple Scleroses as well as patented slow release drug delivery technology for the treatment of type-2 diabetes and arthritis


Fiscal Year End 12/31
OTC Market Tier Pink Sheets Limited

Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company


Incorporated In: DE, USA
Year of Inc. 1998
Employees 9 a/o Dec 31, 2009

Company Officers
Max Arella Dir.
Ian Morrice EVP
Jean Francis Amyot VP, Bus. Affairs

Company Notes
•Formerly=EmergenSys Corp. until 10-2009
•Formerly=Medical Licensing International Corp. until 12-03
•Formerly=MoliChem Medicines, Inc. until 7-03
•Formerly=Cortez Development Ltd. until 3-01
SPPH Security Details
Share Structure
Market Value1 $74,945,094 a/o Dec 10, 2010
Shares Outstanding 258,431,359 a/o Jun 30, 2010
Float 45,429,759 a/o Feb 25, 2010

Authorized Shares 480,000,000 a/o Jun 30, 2010
Par Value 0.0010

Shareholders
Shareholders of Record 109 a/o Feb 25, 2010
Beneficial Shareholders N/A

Corporate Actions
Ex. Date Record Date Pay Date

Security Notes
•Capital Change=shs increased by 6.959314 for 1 split Ex-date=01/26/2001. Rec date=01/11/2001. Pay date=01/25/2001.


Non US Stock Exchange Listing
-

Short Selling Data
Short Interest 40,264 (100%)
Nov 30, 2010
Significant Failures to Deliver No

Transfer Agent(s)
Interwest Transfer Co., Inc.
Service Providers
Auditor/Accountant

Laposta & Associates
8530 Champ D'Eau
PQ, H1P 1Y3
United States


Legal Counsel

Mitch Segal, Attorney at Law
626 RXR Plaza
NY, 11556
United States


Investor Relations Firm

Hilbroy Advisory Inc.
1400 Begin
QC, H4R1X1
Canada